{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:03:10Z","timestamp":1791187390954,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.068","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T07:27:06Z","timestamp":1260343626000},"page":"2149-2156","source":"Crossref","is-referenced-by-count":131,"title":["Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity"],"prefix":"10.1016","volume":"28","author":[{"given":"Robert B.","family":"Belshe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Coelingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xionghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1416","key":"10.1016\/j.vaccine.2009.11.068_bib1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1098\/rstb.2001.0999","article-title":"The evolution of human influenza viruses","volume":"356","author":"Hay","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.068_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijid.2005.10.008","article-title":"Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus","volume":"11","author":"Hite","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.068_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcv.2007.11.026","article-title":"Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan","volume":"42","author":"Li","year":"2008","journal-title":"J Clin Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.11.068_bib4","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1371\/journal.pmed.0040247","article-title":"Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City","volume":"4","author":"Olson","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.068_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.068_bib6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ije\/24.6.1240","article-title":"Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons","volume":"24","author":"Ohmit","year":"1995","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.068_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/INF.0b013e31816be008","article-title":"Clinical features of children infected with different strains of influenza B in southern Taiwan","volume":"27","author":"Chi","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.068_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0002-9343(80)90352-6","article-title":"Severe illness with influenza B","volume":"68","author":"Baine","year":"1980","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.068_bib9","first-page":"95","article-title":"Clinical features of influenza A and B in children and association with myositis","volume":"37","author":"Hu","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.11.068_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.virusres.2006.11.005","article-title":"Characterization of the epidemic influenza B viruses isolated during 2004\u20132005 season in Taiwan","volume":"124","author":"Lin","year":"2007","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.068_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00705-006-0852-6","article-title":"Exploration of the emergence of the Victoria lineage of influenza B virus","volume":"152","author":"Chen","year":"2007","journal-title":"Arch Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2009.11.068_bib12","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1128\/JVI.78.23.12817-12828.2004","article-title":"Multiple genotypes of influenza B virus circulated between 1979 and 2003","volume":"78","author":"McCullers","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.11.068_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1719","article-title":"Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000\u20132001 and 2001\u20132002 seasons","volume":"303","author":"Shaw","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.11.068_bib14","unstructured":"Centers for Disease Control and Prevention. Update: Influenza activity \u2014 United States, September 28, 2008\u2013April 4, 2009, and composition of the 2009\u201310 influenza vaccine. MMWR 2009;58(14)April 17, 2009:369\u201374."},{"key":"10.1016\/j.vaccine.2009.11.068_bib15","unstructured":"MedImmune, Data on file."},{"key":"10.1016\/j.vaccine.2009.11.068_bib16","unstructured":"Centers for Disease Control and Prevention. Vaccines and Related Biological Products Advisory Committee Meeting (January 30, 2001). Available at http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/slides\/3680s1.htm."},{"key":"10.1016\/j.vaccine.2009.11.068_bib17","unstructured":"Centers for Disease Control and Prevention. Vaccines and Related Biological Products Advisory Committee Meeting (January 30, 2002). Available at http:\/\/www.fda.gov\/OHRMS\/DOCKETS\/ac\/02\/slides\/3835S1_03.pdf."},{"key":"10.1016\/j.vaccine.2009.11.068_bib18","unstructured":"Centers for Disease Control and Prevention. Vaccines and Related Biological Products Advisory Committee Meeting (March 17, 2004). Available at http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/4020B2_1.pdf."},{"key":"10.1016\/j.vaccine.2009.11.068_bib19","unstructured":"Centers for Disease Control and Prevention. Vaccines and Related Biological Products Advisory Committee Meeting (February 17, 2006). Available at http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/06\/slides\/2006-4207S1_02a-b-c_revised.pdf."},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.068_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.068_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.vaccine.2009.11.068_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.068_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.068_bib24","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.068_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/aje\/kwg163","article-title":"Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures","volume":"158","author":"Halloran","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.11.068_bib26","unstructured":"Hoft DF, Worku S, Lottenbach K, Stanley J, Spencer C, Babusis E, et al. Live attenuated influenza vaccine (LAIV), but not trivalent inactivated vaccine (TIV), induces functional CD4+ CD8+ and \u03b3\u03b4 T cell responses in children relevant for pandemic influenza. [Abstract S14]. The twelfth annual conference on vaccine research; 2009 April 27\u201329; Baltimore, MD, USA."},{"key":"10.1016\/j.vaccine.2009.11.068_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/INF.0b013e31819219b8","article-title":"Efficacy and safety of one and two doses of live attenuated influenza vaccine in vaccine-naive children","volume":"28","author":"Bracco Neto","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.068_bib28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31806166f8","article-title":"Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia","volume":"26","author":"Tam","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.068_bib29","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1542\/peds.2006-0725","article-title":"Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care","volume":"118","author":"Vesikari","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.068_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.inf.0000220229.51531.47","article-title":"A randomized double-blind study of the safety, transmissibility, and phenotypic and genotypic stability of cold-adapted influenza virus vaccine (LAIV, FluMist\u00ae)","volume":"25","author":"Vesikari","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.11.068_bib31","article-title":"Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children","author":"Lum","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.11.068_bib32","unstructured":"Belshe R, Ambrose C, Walker R, Yang C, Yi T, Hultquist M, et al. Genetic sequences of circulating 2004\u20132005 influenza strains and serum antibody responses to LAIV vs TIV in young children. Joint meeting of the pediatric academic societies and Asian Society for Pediatric Research; 2008 May 2\u20136; Honolulu, HI."},{"key":"10.1016\/j.vaccine.2009.11.068_bib33","unstructured":"Couch RB. Vaccines and Related Biological Products Advisory Committee: background and presentation of possible vaccine options. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/slides\/2007-4282S2_11.ppt. Accessed July 28, 2009."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T13:59:20Z","timestamp":1544795960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09018714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09018714"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}